KANK2 and thyroid gland carcinoma: When compared to normal tissues, which comprise 18,102 samples, KANK2 mRNA expression was significantly reduced in BLCA, BRCA, CESC, ESCA, COAD, KICH, KIRP, LUAD, LUSC, PRAD, READ, STAD, thyroid carcinoma (THCA), and UCEC (p < 0.001).